State Street Corp Eagle Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 35,820 shares of EGRX stock, worth $29,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,820

Previous 35,820 -0.0%

Holding current value

$29,730

Previous $200,000 34.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.34 - $5.6 $594,008 - $995,943	-177,847 Reduced 83.24%	35,820 $200,000
Q1 2024 May 15, 2024	SELL	$4.26 - $6.51 $38,029 - $58,114	-8,927 Reduced 4.01%	213,667 $1.12 Million
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $68,630 - $225,457	14,823 Added 7.13%	222,594 $1.16 Million
Q3 2023 Nov 14, 2023	SELL	$15.21 - $22.88 $455,402 - $685,050	-29,941 Reduced 12.6%	207,771 $3.28 Million
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $2.93 Million - $5.27 Million	-165,206 Reduced 41.0%	237,712 $4.62 Million
Q1 2023 May 15, 2023	SELL	$25.06 - $34.09 $13.8 Million - $18.7 Million	-549,108 Reduced 57.68%	402,918 $11.4 Million
Q4 2022 Feb 14, 2023	SELL	$24.98 - $39.77 $1.49 Million - $2.38 Million	-59,721 Reduced 5.9%	952,026 $27.8 Million
Q3 2022 Nov 15, 2022	BUY	$26.42 - $47.12 $6.23 Million - $11.1 Million	235,887 Added 30.4%	1,011,747 $26.7 Million
Q2 2022 Aug 15, 2022	BUY	$41.26 - $51.35 $2.47 Million - $3.08 Million	59,976 Added 8.38%	775,860 $34.5 Million
Q1 2022 May 16, 2022	BUY	$44.58 - $52.6 $341,482 - $402,916	7,660 Added 1.08%	715,884 $35.4 Million
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $33,036 - $41,024	-721 Reduced 0.1%	708,224 $36.1 Million
Q3 2021 Nov 15, 2021	SELL	$43.79 - $55.78 $1.26 Million - $1.61 Million	-28,841 Reduced 3.91%	708,945 $39.5 Million
Q2 2021 Aug 16, 2021	SELL	$36.86 - $44.5 $2.39 Million - $2.88 Million	-64,798 Reduced 8.07%	737,786 $31.6 Million
Q1 2021 May 17, 2021	SELL	$40.32 - $50.97 $464,365 - $587,021	-11,517 Reduced 1.41%	802,584 $33.5 Million
Q4 2020 Feb 16, 2021	BUY	$41.72 - $51.34 $794,599 - $977,821	19,046 Added 2.4%	814,101 $37.9 Million
Q3 2020 Nov 10, 2020	BUY	$37.02 - $51.28 $564,851 - $782,430	15,258 Added 1.96%	795,055 $33.8 Million
Q2 2020 Aug 14, 2020	BUY	$43.24 - $55.02 $6.67 Million - $8.49 Million	154,327 Added 24.67%	779,797 $37.4 Million
Q1 2020 May 11, 2020	BUY	$34.37 - $60.07 $21.5 Million - $37.6 Million	625,470 New	625,470 $28.8 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.59M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $10.8M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Eagle Pharmaceuticals, Inc. Transaction History